Diagnostic & Investigational Procedures
OncoCheck-Apheresis
An advanced molecular diagnostic program developed to obtain highly valuable biological information directly from circulating blood cells.
Overview
OncoCheck is an advanced molecular diagnostic program developed to obtain highly valuable biological information directly from circulating blood cells.
Unlike conventional blood testing, which analyzes plasma or serum markers, OncoCheck™ utilizes specialized apheresis technology to collect a concentrated population of circulating mononuclear cells. These cells provide access to a rich source of biological information that can be evaluated using modern molecular analysis techniques.
The program combines advanced cell collection, molecular biology, bioinformatics, and clinical interpretation into one integrated precision medicine platform.
OncoCheck-Apheresis is an advanced molecular analysis platform designed to evaluate biological activity, immune function, gene expression patterns, and individualized health optimization opportunities.
Target Population
- Individuals seeking advanced molecular health assessment
- Patients interested in personalized medicine approaches
- Individuals with complex or unclear medical conditions
- Patients requiring deeper biological and immunological evaluation
- Preventive and longevity medicine programs
- Integrative oncology support programs
Program Highlights
- Molecular Biomarker Analysis
- Gene Expression Profiling
- Immune Activity Assessment
- Personalized Medical Report
- Physician Consultation
Gallery
Further procedures
Medical assessment before procedure
The availability of a procedure does not mean that it is appropriate for every patient. Before any procedure is considered, the patient's medical history, current clinical situation, available diagnostic information and relevant medical factors are evaluated.
No diagnostic or therapeutic procedure can guarantee a specific clinical outcome.